Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells

Gynecologic Oncology

Volumn 111, Issue 2, 2008, Pages 344-349

  Stefanidis, Konstantinos ^a   Loutradis, Dimitris ^a   Vassiliou, Leandros Vassilios ^a   Anastasiadou, Vasiliki ^a   Kiapekou, Erasmia ^a   Nikas, Vasilis ^a   Patris, Giorgos ^a   Vlachos, Georgios ^a   Rodolakis, Alexandros ^a   Antsaklis, Aris ^a  

^a Alexandra Maternity Hospital 1st Department of Obstetrics and Gynecology   (Greece)

Author keywords

Cervical carcinoma; DAZL; Nevirapine; Oct 4; Senescence

Indexed keywords

CHECKPOINT KINASE 2; DIMETHYL SULFOXIDE; NEVIRAPINE; PROTEIN P21; PROTEIN P53; THREONINE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DRUG ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA;

CELL AGING; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; DNA DAMAGE; FEMALE; HELA CELLS; HUMANS; NEVIRAPINE; UTERINE CERVICAL NEOPLASMS;

EID: 55649104114     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.08.006     Document Type: Article

References (24)

1. Gollin S.M. Mechanisms leading to chromosomal instability. Seminars in Cancer Biology 15 (2005) 33-42
2. Deragon J.M., Sinnett D., and Labuda D. Reverse transcriptase activity from human embryonal carcinoma cells NTera2D1. EMBO J. 9 10 (1990) 3363-3368
3. Martin S.L., and Branciforte D. Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells. Mol. Cell. Biol. 13 9 (1993) 5383-5392
4. Spadafora C. Endogenous reverse transcriptase: a mediator of cell proliferation and differentiation. Cytogenet Genome Res. 105 2-4 (2004) 346-350
5. Mangiacasale R., Pittoggi C., Sciamanna I., et al. Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation. Oncogene 22 18 (2003) 2750-2761
6. Sciamanna I., Landriscina M., Pittoggi C., et al. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 24 24 (2005) 3923-3931
7. Landriscina M., Fabiano A., Altamura S., Bagalà C., Piscazzi A., Cassano A., et al. Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. J. Clin. Endocrinol. Metab. 90 10 (2005) 5663-5671
8. Landriscina M., Modoni S., Fabiano A., et al. Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine. Lancet Oncol. 7 10 (2006) 877-879
9. Ren J., Nichols C., Bird L., et al. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J. Mol. Biol. 312 4 (2001) 795-805
10. Merluzzi V.J., Hargrave K.D., Labadia M., et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 250 4986 (1990) 1411-1413
11. Pittoggi C., Sciamanna I., Mattei E., Beraldi R., Lobascio A.M., Mai A., et al. Role of endogenous reverse transcriptase in murine early embryo development. Mol. Reprod. Dev. 66 3 (2003) 225-236
12. Dimri G.P., Lee X., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 20 (1995) 9363-9367
13. Sidransky D., Frost P., Von Eschenbach A., Oyasu R., Preisinger A.C., and Vogelstein B. Clonal origin bladder cancer. N. Engl. J. Med. 326 (1992) 737-740
14. Trosko J.E. From adult stem cells to cancer stem cells: Oct-4 gene, cell-cell communication, and hormones during tumor promotion. Ann. N. Y. Acad. Sci. 1089 (2006) 36-58
15. Gidekel S., Pizov G., Bergman Y., and Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 4 (2003) 361-370
16. Donovan P.J. High Oct-ane fuel powers the stem cell. Nature Genet 29 (2001) 246-247
17. Pesce M., and Schöler H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19 (2001) 271-278
18. Seligman J., and Page D.C. The Dazl gene is expressed in male and female embryonic gonads before germ cell sex differentiation. Biochem. Biophys Res. Commun. 245 (1998) 878-882
19. Al-Hajj M., and Clarke M.F. Self-renewal and solid tumor stem cells. Oncogene 23 (2004) 7274-7282
20. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 7119 (2006) 633-637
21. Chehab N.H., Malikzay A., Appel M., and Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14 3 (2000) 278-288
22. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res. 63 11 (2003) 2705-2715
23. Chang B.D., Xuan Y., Broude E.V., et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18 34 (1999) 4808-4818
24. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 7035 (Apr 14 2005) 907-913